Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy

Kidney International

Volumn 87, Issue 6, 2015, Pages 1209-1215

  Liao, Jo Nan ^a,b   Chao, Tze Fan ^a,b   Liu, Chia Jen ^a,b   Wang, Kang Ling ^a,b   Chen, Su Jung ^a,b   Lin, Yenn Jiang ^a,b   Chang, Shih Lin ^a,b   Lo, Li Wei ^a,b   Hu, Yu Feng ^a,b   Tuan, Ta Chuan ^a,b   Chung, Fa Po ^a,b   Chen, Tzeng Ji ^a   Chen, Shih Ann ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

atrial fibrillation; chronic kidney disease; end stage renal disease; risk factors

Indexed keywords

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; END STAGE RENAL DISEASE; FEMALE; HEALTH INSURANCE; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK FACTOR; TAIWAN; AGE; CASE CONTROL STUDY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC;

AGE FACTORS; AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RISK FACTORS; TAIWAN;

EID: 84930277487     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.393     Document Type: Article

References (45)

1. January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1-e76.
2. Camm AJ, Lip GY, De Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-2747.
3. Stewart S, Hart CL, Hole DJ et al. A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359-364.
4. Stewart S, MacIntyre K, MacLeod MM et al. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. Eur Heart J 2001; 22: 693-701.
5. Lee WC, Lamas GA, Balu S et al. Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective. J Med Econ 2008; 11: 281-298.
6. Hart RG, Pearce LA, Rothbart RM et al. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000; 35: 183-187.
7. Hohnloser SH, Pajitnev D, Pogue J et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 2007; 50: 2156-2161.
8. Chao TF, Tsao HM, Ambrose K et al. Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation - the potential role beyond the CHA(2)DS(2)-VASc score. Heart Rhythm 2012; 9: 1755-1760.
9. Olesen JB, Lip GY, Kamper AL et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012; 367: 625-635.
10. Piccini JP, Stevens SR, Chang Y et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 2013; 127: 224-232.
11. Guo Y, Wang H, Zhao X et al. Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation. Int J Cardiol 2013; 168: 1502-1508.
12. Providencia R, Barra S, Paiva L. Chronic renal disease is associated with stroke and thromboembolism in atrial fibrillation independently from gender. Int J Cardiol 2013; 168: 3106-3107.
13. Nelson SE, Shroff GR, Li S et al. Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients. J Am Heart Assoc 2012; 1: e002097.
14. Genovesi S, Pogliani D, Faini A et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 2005; 46: 897-902.
15. Abe S, Yoshizawa M, Nakanishi N et al. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 1996; 131: 1137-1144.
16. Winkelmayer WC, Patrick AR, Liu J et al. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 2011; 22: 349-357.
17. Korantzopoulos P, Liu T, Letsas KP et al. The epidemiology of atrial fibrillation in end-stage renal disease. J Nephrol 2013; 26: 617-623.
18. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail 2001; 23: 71-76.
19. Vazquez-Ruiz de Castroviejoa E, Sanchez-Perales C, Lozano-Cabezas C et al. [Incidence of atrial fibrillation in hemodialysis patients. A prospective long-term follow-up study]. Rev Esp Cardiol 2006; 59: 779-784.
20. Genovesi S, Vincenti A, Rossi E et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 2008; 51: 255-262.
21. Vazquez E, Sanchez-Perales C, Garcia-Garcia F et al. Atrial fibrillation in incident dialysis patients. Kidney Int 2009; 76: 324-330.
22. Wizemann V, Tong L, Satayathum S et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 2010; 77: 1098-1106.
23. Goldstein BA, Arce CM, Hlatky MA et al. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation 2012; 126: 2293-2301.
24. Go AS, Fang MC, Udaltsova N et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009; 119: 1363-1369.
25. Winkelmayer WC, Liu J, Setoguchi S et al. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 2011; 6: 2662-2668.
26. Bansal N, Fan D, Hsu CY et al. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 2013; 127: 569-574.
27. Tuan TC, Chang SL, Tsao HM et al. The impact of age on the electroanatomical characteristics and outcome of catheter ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 966-972.
28. Roh SY, Choi JI, Lee JY et al. Catheter ablation of atrial fibrillation in patients with chronic lung disease. Circ Arrhythm Electrophysiol 2011; 4: 815-822.
29. Hsieh MH, Lin YJ, Wang HH et al. Functional characterization of atrial electrograms in a pacing-induced heart failure model of atrial fibrillation: importance of regional atrial connexin40 remodeling. J Cardiovasc Electrophysiol 2013; 24: 573-582.
30. Alasady M, Shipp NJ, Brooks AG et al. Myocardial infarction and atrial fibrillation: importance of atrial ischemia. Circ Arrhythm Electrophysiol 2013; 6: 738-745.
31. Lau DH, Shipp NJ, Kelly DJ et al. Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. PLoS One 2013; 8: e72416.
32. Kocheril AG. Arrhythmia issues in patients with renal disease. Semin Nephrol 2001; 21: 57-65.
33. Korantzopoulos P, Liu T, Li L et al. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis. Europace 2009; 11: 1469-1475.
34. Grande A. [Atrial fibrillation and dialysis. A convergence of risk factors]. Rev Esp Cardiol 2006; 59: 766-769.
35. Remppis A, Ritz E. Cardiac problems in the dialysis patient: beyond coronary disease. Semin Dial 2008; 21: 319-325.
36. Reiffel JA, Schwarzberg R, Murry M. Comparison of autotriggered memory loop recorders versus standard loop recorders versus 24-hour Holter monitors for arrhythmia detection. Am J Cardiol 2005; 95: 1055-1059.
37. Schnabel RB, Sullivan LM, Levy D et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373: 739-745.
38. Chamberlain AM, Agarwal SK, Folsom AR et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011; 107: 85-91.
39. Chao TF, Liu CJ, Chen SJ et al. CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan. Int J Cardiol 2013; 168: 1360-1363.
40. Luo JC, Leu HB, Huang KW et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011; 183: E1345-E1351.
41. Tai CT, Chen SA, Chiang CE et al. Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter. Circulation 1997; 96: 2601-2611.
42. Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
43. Chen SJ, Liu CJ, Chao TF et al. Dental scaling and atrial fibrillation: a nationwide cohort study. Int J Cardiol 2013; 168: 2300-2303.
44. Chang CH, Lee YC, Tsai CT et al. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease. Atherosclerosis 2014; 232: 224-230.
45. Lin LJ, Cheng MH, Lee CH et al. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation - a nationwide descriptive study in Taiwan. Clin Ther 2008; 30: 1726-1736.